Artemis Hospitals
Transurethral resection of the prostate (TURP) in India typically costs from AUD $2,652 to AUD $5,862. The final price depends on the surgical technique used, the hospital's accreditation level, and the patient's choice of room. Australians save approximately 65% compared to local private prices, which average AUD $11,864. Costs usually cover the surgery, hospital stay, anaesthetic, and initial pathology.
Bookimed Expert Insight: Choosing major networks provides significant value through integrated care. For instance, Apollo Hospital Indraprastha and Manipal Hospitals are JCI-accredited and serve over a million patients annually. This high volume allows them to provide sophisticated care at lower rates than Australian private hospitals. Experienced urologists like Dr. Kumar Ramesh often manage complex cases using advanced technologies while maintaining affordability.
| India | Thailand | Turkey | |
| Transurethral resection of the prostate (TURP) | from AUD $2,582 | from AUD $5,583 | from AUD $3,908 |
No hidden fees – just official clinic prices. Pay at the clinic for Transurethral resection of the prostate (TURP) upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Transurethral resection of the prostate (TURP) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Transurethral resection of the prostate (TURP) journey.
The doctor graduated with a Bachelor of Medicine from Mysore University in 1996, followed by a Doctor of Medicine in radiotherapy from Banaras Hindu University in 2002. Further enhancing expertise, the doctor earned a Diplomate of National Board in radiotherapy in 2004.
The doctor is a member of several prestigious organizations, including the Association of Radiation Oncology of India, the Society for Neuro-Oncology, the Bangalore Oncology Group, and the Indian Association of Hyperthermia Oncology, reflecting a strong commitment to advancing the field of oncology.
Dr. Shruti Kate is a medical oncologist at HCG Manavata Cancer Centre in Nashik. She previously worked as a consultant at the Tata Memorial Hospital in Mumbai. Dr. Kate focuses on immunotherapy and metronomic therapy for treating solid and pediatric tumors. She was the sole recipient from India of the 2018 World Conference on Lung Cancer award.
The doctor is an experienced nuclear medicine specialist at HCG Manavata Cancer Centre with 12 years in the field. The doctor specializes in various nuclear scans, PET-CT scans, and nuclear cardiology services, demonstrating proficiency in radioiodine and Lu-177 RN therapies. Over the course of their career, the doctor has managed more than 30,000 PET scans and treated over 1,000 thyroid cancer patients. Additionally, the doctor has contributed to the field through published papers in various medical journals.
Dr. Shaunak Valame is a medical oncologist at HCG Manavata Cancer Centre in Nashik. He specializes in the molecular basis of cancer and targeted therapies. Dr. Valame completed his DNB training in medical oncology at Indraprastha Apollo Hospital. He previously served as a registrar at Jawaharlal Nehru Cancer Hospital.